APA

Cirillo E., Del Giudice E., Micheli R., Cappellari A. M., Soresina A., Dellepiane R. M., Pietrogrande M. C., Dell'Era L., Specchia F., Pession A., Plebani A. & Pignata C. (20190221). Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study. : European journal of neurology.

Chicago

Cirillo E, Del Giudice E, Micheli R, Cappellari A M, Soresina A, Dellepiane R M, Pietrogrande M C, Dell'Era L, Specchia F, Pession A, Plebani A and Pignata C. 20190221. Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study. : European journal of neurology.

Harvard

Cirillo E., Del Giudice E., Micheli R., Cappellari A. M., Soresina A., Dellepiane R. M., Pietrogrande M. C., Dell'Era L., Specchia F., Pession A., Plebani A. and Pignata C. (20190221). Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study. : European journal of neurology.

MLA

Cirillo E, Del Giudice E, Micheli R, Cappellari A M, Soresina A, Dellepiane R M, Pietrogrande M C, Dell'Era L, Specchia F, Pession A, Plebani A and Pignata C. Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study. : European journal of neurology. 20190221.